Target intelligence / Profile preview

Methylthioadenosine phosphorylase pseudogene 2 (MTAPP2)

Target
MTAPP2
Molecular classification
Other (Pseudogene)
01

Overview

Methylthioadenosine phosphorylase pseudogene 2 (MTAPP2) is a pseudogene—a non-coding DNA sequence resembling the functional methylthioadenosine phosphorylase (MTAP) gene but lacking the ability to produce a functional protein product due to disabling mutations[1]. Pseudogenes like MTAPP2 can occasionally be transcribed, and in rare cases, pseudogene RNA may regulate gene expression through mechanisms such as acting as a microRNA sponge or through antisense interactions, but no specific evidence supports such roles for MTAPP2[2][3][4]. MTAPP2 is not reported as a therapeutic target and does not have known functions in disease, nor is it associated with any drug interactions[1][5]. Key notes and limitations: - MTAPP2 is not a known or plausible therapeutic target and does not encode a receptor, enzyme, transporter, or other druggable entity[1][5]. - As a pseudogene, it is mainly used in genomic annotation and reference, not in clinical or drug development contexts[3]. - Some pseudogenes are implicated in gene regulation at the RNA level, but there is no literature suggesting a regulatory or disease role for MTAPP2 specifically[2][3][4]. - This entry may be inaccurate if used in a list of druggable or clinically actionable targets; in such a case, it should be flagged as incorrect.

Other names
MTAPP2

Beyond the preview

Go deeper on Methylthioadenosine phosphorylase pseudogene 2 (MTAPP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methylthioadenosine phosphorylase pseudogene 2 (MTAPP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call